To include your compound in the COVID-19 Resource Center, submit it here.

Tenapanor: Phase IIb amended

Ardelyx said FDA recommended at an end-of-Phase II meeting that the company use its ongoing, double-blind, placebo-controlled, U.S. Phase IIb trial of

Read the full 227 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE